Sandu Pharmaceuticals Declares Q2 FY27 Unaudited Results

Sandu Pharmaceuticals Ltd announced its unaudited financial results for the quarter and half-year ended September 30, 2026. The company's Board of Directors approved these results in a meeting held on November 14, 2026. The financial statements, prepared in compliance with Ind-AS, were reviewed by the Audit Committee and the Statutory Auditors, M/s Dave & Dave Chartered Accountants. The results are also available on the company's website. Key financial highlights include Revenue from Operations of ₹19,428.8 Lacs for the quarter and ₹23,201 Lacs for the half-year ended September 30, 2026. Profit Before Tax for the quarter stood at ₹859.1 Lacs, and for the half-year at ₹1,219.7 Lacs. Basic Earnings Per Share for the quarter was ₹0.85 and for the half-year was ₹1.08.